SEC Tracker
Get the app

Sionna Therapeutics SION

OrbiMed Private Investments VIII (Shareholder) plans to sell 1,082,480 SION shares, about $46.3M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: May 29, 2026
  2. Broker: TD Cowen
  3. Shares acquired by: IPO
  4. 10b5-1 plan adopted: Feb 10, 2025

All of OrbiMed Private Investments VIII's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 101 shares at $44.49 on May 27, 2026 · Form 4
  • Sold 115,844 shares at $45.5 on Jun 30, 2026 · Form 4
  • Sold 85,918 shares at $44.86 on Jul 7, 2026 · Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Sionna Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Emergent BioSolutions EBS public float $343M, Jun 30, 2025
  2. Northwest Biotherapeutics NWBO public float $340M, Jun 30, 2025
  3. Amarin AMRN public float $335M, Jun 30, 2025
  4. Rigel Pharmaceuticals RIGL public float $332M, Jun 30, 2025
  5. Usana Health Sciences USNA public float $328M, Jun 27, 2025